Scientists Discover New Immune Cell Clue Behind Severe Multiple Sclerosis
June 30, 2026: Researchers have uncovered a significant biological clue that could help explain why some people with multiple sclerosis (MS) experience more severe disease than others. The discovery centers on a unique group of immune cells known as “foamy” immune cells, which were found in greater numbers within the brains of patients suffering from advanced forms of the neurological disorder.
Multiple sclerosis is a chronic autoimmune disease in which the body’s immune system mistakenly attacks the protective covering of nerve fibers, disrupting communication between the brain and the rest of the body. While treatments have improved over the years, scientists have continued searching for the underlying mechanisms that drive disease progression.
In the latest study, researchers analyzed brain tissue samples and observed that these foamy immune cells accumulate in damaged regions of the brain. Unlike normal immune cells, they contain large amounts of fatty substances, giving them a foam-like appearance under the microscope. Scientists believe these cells may play an active role in sustaining inflammation and accelerating nerve damage.
The findings suggest that the presence of foamy immune cells could serve as an important biological marker for identifying patients at higher risk of severe neurological decline. Understanding how these cells develop and behave may also open the door to therapies specifically designed to target harmful immune activity while protecting healthy brain tissue.
Medical experts say the research represents an important step toward precision medicine in multiple sclerosis. Instead of treating all patients in the same way, future therapies could be tailored according to the biological processes occurring inside each individual’s brain.
Although additional studies and clinical trials are required before the discovery can be translated into new treatments, researchers are optimistic that the findings will improve both diagnosis and long-term disease management.
As scientists continue to explore the complex interactions between the immune system and the brain, this breakthrough offers renewed hope that more effective and personalized therapies for multiple sclerosis may eventually become a reality.
